About the Company
harnessing the full power of cell therapeutics. cambridge, ma
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SGTX News
Sigilon Therapeutics’ stock soars 550% after Eli Lilly agrees to acquire company
Eli Lilly & Co. said Thursday it has agreed to acquire Sigilon Therapeutics Inc. in a deal worth up to $309.6 million, sending Sigilon’s stock up 550%. The deal for Sigilon which is expected to ...
Sigilon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today reported ...
Delcath Systems Appoints Martha Rook As COO
Delcath Systems Inc. (DCTH) said it appointed Martha Rook as its Chief Operating Officer. Martha Rook has more than 25 years of ...
Douglas G. Cole's Net Worth
Foghorn Therapeutics Inc., Denali Therapeutics Inc., and Sigilon Therapeutics, Inc.. Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro!
12 Best Biotech Penny Stocks to Invest In
In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these ...
Carriage Servs Stock (NYSE:CSV), Quotes and News Summary
Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14. ...
CVKD Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart ...
Omega Therapeutics Inc OMGA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
ZVRA Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes ...
Leap Therapeutics Inc LPTX
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Sarepta Therapeutics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Akero Therapeutics Inc (AKRO)
Jonathan Young, the Chief Operating Officer of Akero Therapeutics, Inc. (NASDAQ:AKRO), has recently sold shares of the company's common stock, generating over $18,000 in the... Akero Therapeutics ...
Loading the latest forecasts...